Library / Laws / 116th Congress / House Bills / H.R. 5444
H.R. 5444
To amend the Biologics Price Competition and Innovation Act of 2009 to streamline the transition of certain products from approval as a drug to licensure as a biological product, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-12-17 | 5.7K | ⠃⠗⠋ |